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Etiology of Anorexia Nervosa: The Interplay Between Genetics and Environment 
 
Introduction  
 Anorexia nervosa is just one of many eating disorders that exist and can cause 
significant hardship and damage in patients who suffer from the disorder.  Treatment of eating 
disorders is often lengthy and complex, and part of the difficulty in reaching recovery is the 
variation in etiology of disease.  While no single event or trait is known to cause an eating 
disorder, current literature suggests that genetics likely play a significant role in the 
development of anorexia nervosa.  Anorexia nervosa (hereon abbreviated as AN)  is defined as 
the “persistent restriction of energy intake relative to requirements leading to significantly low 
body weight”1.  Another part of the diagnostic criteria as defined by the DSM-5 is an “intense 
fear of gaining weight or of becoming fat, or persistent behavior that interferes with weight 
gain, even though at a significantly low weight”2.  A third piece of the diagnostic puzzle includes 
the patient’s perception of his or her weight.  The patient will experience weight in a disturbed 
way and weight has an increased influence on self-evaluation.  A patient could also neglect any 
recognition of the seriousness of a dangerously low weight2.  Two subtypes of AN are defined: 
ANR is the restricting subtype in which patients restrict their caloric intake without any binging 
or purging behavior, and the second subtype is ANBP in which a patient will engage in binge 
and purge behaviors1.  When looking at both AN types as well as all other eating disorders, the 
prevalence is 5% in Western countries3,4.  The lifetime prevalence of anorexia nervosa 
specifically is 1.20% for females and 0.29% for males3,5.  While the prevalence of the disorder in 
males is less than that in females, there is a higher lifetime risk of developing anorexia nervosa 
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within a family in which a male has been diagnosed with the disorder3.   Anorexia nervosa has 
the highest mortality rate of all psychiatric disorders with a 5% mortality rate per decade and 
0.56% per year4.  Aside from the serious consequence of death, AN is also associated with high 
rates of both medical complications and psychiatric comorbidities which will be discussed 
later5.  First degree relatives of someone with AN have a tenfold greater risk of developing AN 
during their lifetime than do those with no relatives who have been diagnosed with AN.  
Relatives of an individual with AN also have a higher risk of developing any eating disorder, 
including those other than AN4.  Despite the awareness of these risk factors and the risk of 
death from the disorder, there has been no well replicated evidence of effective psychological 
or pharmacologic treatment6.  This paper will explore the possible genetic causes of AN, how 
environment plays into one’s genetics to influence development of the disorder, and how these 
findings can influence the future of the field of eating disorder treatment. 
 
Study Designs 
 Three main types of studies have been conducted thus far to analyze possible genetic 
underpinnings of the disorder.  These types include family studies, twin studies, and genome-
wide association studies (abbreviated as GWAS).  The methodology of a family study is that it 
“compares the prevalence of a trait of interest in family members of individuals with the trait of 
interest to family members of those without the trait of interest”5.  In the case of AN, the 
prevalence of this disorder would be studied in families that include a family member who has 
been diagnosed with AN to the prevalence of AN in families in which no member has been 
diagnosed with AN.  These studies have determined that AN does aggregate in families.  
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Heritability estimates that have been replicated range from 48-74%, indicating that about half 
to three quarters of individual variability in AN development is genetic and can be passed down 
in families5.   
 Twin studies seek to observe the similarities and differences between twins who have 
the diagnosis of interest.  In twin studies, “correlations between monozygotic and dizygotic 
twins for a trait of interest are compared to determine the extent to which variation in the trait 
is due to genetic and environmental factors.”5.  It is assumed that monozygotic twins share 
100% of their genetic makeup, and dizygotic twins share 50% of their genes.  Following this 
logic, if a trait is twice as strong in monozygotic twins than it is in dizygotic twins, this would 
prove that genetics are implicated in the development of that trait5.  Twin studies are limited by 
the availability of subjects since twins with AN are not as abundant as non-twins with AN in the 
general population.  It is also difficult to do twin studies in males given the low prevalence of 
AN among males.   
 GWAS, genome-wide association studies, are a strong option for looking at genetic links.  
In this study design, individuals that have a certain trait are compared with those who lack the 
trait of interest.  The comparison is done on 300,000 to 1,000,000 genetic markers across the 
genome.  The GWAS studies are considered the best option of a study because of this method.  
These studies are able to look at millions of genetic loci in many individuals to gather a robust 






 The three types of studies mentioned above have led to various findings and revelations 
about the etiology and nature of anorexia nervosa.  The disorder is polygenic, psychiatric, and 
metabolic.  Polygenic indicates that many genes with small effects contribute to the overall 
development of the disorder5.  Table 1 identifies major genes, their functions, and how a 
change in these genes can contribute to the development of AN.  Genetic correlations have also 
proven that AN is a psychiatric disorder as well as a metabolic one, and it affects both the mind 
and the body6.  A separate GWAS study found a significant signal for AN that was also linked to 
Type I diabetes and other autoimmune conditions, showing that risk for autoimmune issue and 
AN might be linked7.  
Serotonin and dopamine, two neurotransmitters, are critical pieces of AN development.  
Serotonin is involved in appetite regulation and behavior.  Certain features of AN, which will be 
later discussed in this paper, have a proven link with serotonin.  Perfectionism, obsessionality, 
and rigidity are serotonin related traits linked with AN.  SSRIs, drugs that block the reuptake of 
serotonin in order to increase the circulating level, are often part of AN treatment4.  The 
HTR2A, 5-HTTLPR, and ESSRA genes are all related to serotonin (see Table 1) and, when altered, 
affect the neurotransmitter in a way that can lead to AN.  Dopamine is tied to AN as well 
because increased dopaminergic activity can lead to food aversion, weight loss, hyperactivity, 
menstrual dysfunction, distorted body image, and obsessive-compulsive behavior and all of 
these traits are potential traits of AN.  The D2 and D4 dopamine receptor genes have 
polymorphisms that can genetically contribute to AN development4. 
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Table 1.  Relevant genes in the development of anorexia nervosa 
Gene Function Changes in gene that 
increase risk of AN 
HTR2A gene Encodes for a receptor of 
serotonin8  
A allele of the −1438G/A 
polymorphism is more 
common in individuals with 
AN 
 
5-HTTLPR Codes for serotonin 
transporter 
Deletion or insertion into this 
gene creates long and short 
alleles, short allele is 
associated with AN 
EBF1 Protein coding gene Inactivation of the gene 
causes decreased leptin, 
consistent with low leptin in 
AN 
ESRRA Induce expression of 
monoamine oxidase A and B 
Plays a role in metabolism of 
monoamine 
neurotransmitters (ex. 
serotonin and dopamine) 
HDAC4 Protein coding gene Mediated by estrogen, could 
explain why AN is more 
common in females 
 
 
Linkage disequilibrium score regression and cross trait analysis 
 There are methods available to test the genetic overlap between disorders, and two of 
the possible testing methods have been applied to AN5.  One of these methods is cross trait 
analysis.  Cross trait analysis studies genetic variations in a GWAS.  This method of study looks 
at certain variations and determines whether variations that lead to the development of one 
phenotype are also associated with a second phenotype.  The association is determined based 
on a significant threshold that is pre-determined such as choosing a certain number of the most 
significant single nucleotide polymorphisms (SNPs)5.      
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A second method of overlap identification that has been applied to AN is linkage 
disequilibrium score regression (LDSC).  Linkage disequilibrium is a method that uses the 
summary statistics from a GWAS and analyzes them in order to make sure that confounding 
does not increase the number of false positives9.  The LDSC is a statistical method that is used 
to determine the genetic correlation between different occurring phenotypes.  Since 
environmental effects are shared when using the LDSC method, it is unlikely to be affected by 
confounding10.  An LDSC uses summary statistics from a GWAS for the cases and controls and it 
is not biased by sample overlap, making it a good method to use for studying correlations5.   
 LDSC has led to findings related to AN.  Genetic changes that predispose someone to 
schizophrenia also increases that individual’s risk for AN.  Having genetic variants that 
predispose someone to a higher than normal BMI decreases the risk of developing AN5.  In 
2017, the largest LDSC was done and it concluded that there is positive genetic correlation with 
the following traits or conditions and AN: neuroticism, schizophrenia, educational attainment, 
cross disorder psychiatric risk, and HDL cholesterol5.     
 
Traits that increase risk 
 As discussed above, certain conditions are likely to overlap with AN.  Additionally, 
various traits have been identified as traits that can increase an individual’s risk of developing 
AN.  Some of the traits that predispose someone to AN are personality and behavior related.  
These traits are as follows: 
 Perfectionism3 
 Negative self-evaluation3 
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 Obsessive compulsive5 
 Neuroticism5 
 Negative emotionality5 
 Harm avoidance5 
 Low self-directedness5 
 Low cooperativeness5 
Neuroticism was found in multiple sources to be a risk factor for developing AN.  
Neuroticism is defined as “a broad personality trait dimension representing the degree to which 
a person experiences the world as distressing, threatening, and unsafe”11.  Individuals who are 
neurotic can range from emotionally stable to emotional chaos, and those who are highly 
neurotic change emotions very frequently.  Neuroticism itself is a genetic trait with heritability 
estimates ranging from 40-60%, and this indicates that risk of AN is genetic since these traits of 
neuroticism contribute to risk of AN and can run in families11. 
Other factors that contribute to AN are based on socioeconomic description of an 
individual including his or her education level and age.  Young people and those with a high 
education level, especially a college education, are at a higher risk for AN than those without 
these characteristics3,6.  Other psychiatric disorders can also predispose someone to 
development of AN.  Those who do develop the eating disorder are more likely to have major 
depressive disorder, generalized anxiety disorder, or features of avoidant personality 
disorder3,5.  Physically, BMI correlates with AN.  Those who suffer from AN were found to have 
a lower BMI than those who do not, even when controlling for current AN.  AN patients are 
likely to have a lower BMI than those who do not have the diagnosis even after weight 
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restoration and recovery.  This low weight contributes to a protective effect of AN against 
becoming overweight.  The mechanism of this protection is unclear in the literature, but it is 
suspected that low level symptoms of AN continue even after treatment and recovery.  A mild 
level of caloric restriction and increased exercise can contribute to maintenance of a low 
weight3.  A second hypothesis for the return to a low weight after recovery is a genetically low 
set point weight that could be common in AN.  It is highly likely that a low set point weight is 
genetic considering the negative correlations between high weight and AN.  A study found that 
there is a negative correlation between AN and high weight related phenotypes.  A high BMI 
and hip circumference, as well as a BMI in the normal and overweight ranges, all negatively 
correlate with risk for AN6.   
 
Bulik study and Clarke study 
 Two particular studies led to conclusions on heritability estimates of AN and genetic 
differences that change perception of weight and shape.  A study led by Dr. Cynthia Bulik was 
conducted using the largest population-based registry of twin births in the world.  The Swedish 
twin registry was the source of subjects for a large twin study on AN.  The study was conducted 
over the course of 4 years and ended in 2004.  In this study, a diagnosis of anorexia nervosa was 
defined as: a hospital discharge record with the diagnosis of AN, a diagnosis based off of the 
screening of twins for the disorder, or the national cause of death registry with AN listed as a 
diagnosis.  Three different variations of AN were defined.  All source AN is a form of the 
disorder in which full DSM IV criteria were met based on an interview, the registry discharge 
had a diagnosis of AN, or the death certificate had the AN diagnosis.  Narrow DSM IV AN is 
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defined as a patient meeting full DSM IV diagnostic criteria via interview, and Broad DSM IV AN 
is defined as a patient meeting full DSM IV diagnostic criteria with the exception of amenorrhea 
since it has been proven an unreliable diagnostic criterion.  In this study, the heritability of 
narrow and broad AN respectively were found to be 0.56 and 0.313.  Heritability can range from 
0.0 to 1.0, and for most human behavior the estimates are usually between 0.30 and 0.6012.  An 
estimate close to zero would indicate that all, or almost all, of the variation in a given trait 
among individuals is due to environmental influences and there is little genetic influence.  Some 
examples of traits with a heritability of zero (those that are not at all tied to genes) are 
language spoken, religion, and political affiliation13.  The values from this study indicate that 31-
56% of individual differences observed in AN are due to genetic differences among the 
individuals3.  What heritability does not tell us is the proportion of a given trait that is 
determined by genetics; it does not indicate that 31% of AN symptoms are genetic.  Rather, the 
heritability value speaks to individual variance and how the differences in the trait among the 
population are tied to genetic differences12.   
 Another study of interest looked at brain function via fMRI tests to observe reactions to 
images based on the genetic variations of the individuals studied.  This study suggests that AN 
could be related to an alteration in reward and emotional processing1.  During the study, 
subjects underwent fMRI testing.  A functional MRI is a technique that maps brain activity while 
a subject alternates between a task and a control state.  In this case, the task was looking at 
images of naked female bodies and the fMRI mapped brain activity during the task to look at 
the response to bodies of different sizes.  Participants in the study were instructed to rate on a 
given scale how they would feel if they had the same body shape as the person portrayed in the 
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image1.  Before participating in the fMRI test, subjects underwent genetic testing via a saliva 
sample.  The sample was tested for presence of the Val66Met polymorphism.  AN patients who 
did have the polymorphism (those who carried Met rather than a Val homozygote) had a higher 
frequency of skin conductance response (SCR) when visually processing images of underweight 
bodies than those without the polymorphism1.  The skin conductance response is a 
phenomenon that causes skin to become a better conductor of electricity for a moment while 
an external or internal stimulus is arousing.  This is how reactions to the images were measured 
in study subjects.  Since the group of AN patients with the polymorphism had a higher SCR 
when viewing underweight images, they were more mentally stimulated in a positive way by 
these underweight bodies, indicating positive reinforcement of this appearance.   
A specific variant of the polymorphism observed in this study, the rs6265 variant of 
Val66Met, is associated with higher secretions of BDNF (brain derived neurotrophic factor- a 
neutrophin that is necessary for the development and survival of neurons14) and altered levels 
of BDNF are associated with susceptibility to EDs1.  Animal models have also shown that BDNF 
suppresses appetite and can lead to weight loss4.  These changes can also be implicated in ED 
development, especially AN.  Overall, the study found that there was a higher positive response 
when processing underweight stimuli in patients vs. controls and the overall heritability 






Limitations of Current Research 
 The studies that have been conducted thus far on the genetic causes of anorexia 
nervosa largely suffer from similar limitations.  A common criticism is that the studies have a 
small sample size.  Difficulty increasing sample sizes is problematic because of the low 
prevalence of the disorder.  Twin studies, as discussed earlier, are a popular method used for 
studying the genetics of AN, but twins with the disorder can be hard to come by.  Twin studies 
have also only been done in females since AN is not as prevalent in males as it is in females5.  
Due to small sample sizes, the studies that have been conducted have low statistical power.  
With low power, there is increased chance of error in the studies.  rGE studies (gene-
environment correlation studies) have not yet been done on AN, and this would be a beneficial 
analysis of the disorder.  These types of studies look at the outcome of a subject with a genetic 
predisposition for AN entering an environment that puts them at a higher risk of developing AN 
such as a weight focused sport1.   This type of study is crucial for advancing understanding of 
AN’s etiology since it seems to be a combination of genetic and environmental causes.  Other 
limitations of current studies include unclear changes in prevalence.  The Bulik study showed an 
increased prevalence of AN as compared to prior populations, but the increase in prevalence 
could be due to increases in diagnosis.  Many cases likely remain undiagnosed so the 
prevalence is not truly known.  Some studies have come up with mixed results and replication is 
needed to clarify findings4.  In addition to replication, diagnostic criteria need to be solidified.  
Genetic associations can be difficult to conclude because of the diagnostic criteria.  Clearer 
criteria would lead to a more homogeneous sample to study5. 
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The Role of Environmental Factors  
Dr. Bulik has been quoted saying your “genes load the gun, environment pulls the 
trigger” in reference to development of AN.  Genetic causes have been discussed above, and 
many of these studies also touched on environmental contributors to the disease.  The 
following environmental factors increase one’s risk of developing AN: 
 Childhood trauma3 
 Sexual abuse5 
 Overprotective family dynamic5 
 Intrusive family5 
 Controlling family5 
 Emotionally unresponsive parents5 
 Preoccupation with weight within the family5 
Athletic competition5 
It is even suggested that environmental exposures, if strong enough, can cause epigenetic 
alterations such as hypermethylation that are associated with AN5.  When anyone with a 
genetic predisposition to AN is put in an environmental situation such as those listed above, the 
chance of developing AN becomes higher.  That is further evidence that environmental factors 
do play a strong role in AN development10.   
 
What needs to be done 
 At this point, more research is needed to determine clear causes of AN.  New studies 
need increased sample sizes to increase the statistical power of the studies.  In order to 
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increase sample size, inclusion of heterogeneous cases may be necessary7.  It will also be 
helpful in future studies to look at endophenotypes.  Endophenotypes are intermediate 
phenotypes, characteristics that are not easily observed at a surface level but can make 
someone more susceptible to a particular condition15.  Studying endophenotypes can be a 
better way to detect genetic risk because endophenotypes are related to fewer genes than are 
specific phenotypes1.  It remains uncertain whether or not information about genetic risk 
should be communicated with patients who are diagnosed with AN.  Advocates for this 
communication believe that it could reduce stigma surrounding the disorder, but opponents 




 Given the current findings about genetic causes of anorexia nervosa, prevention of this 
disorder should be a high priority in the field of nutrition.  Since it is impossible to know based 
on looking at someone whether or not they are at a genetic risk of developing AN, nutrition 
educators should be communicating with all people as if they are at risk.  There is no well 
documented effective treatment for AN, and that makes prevention even more vital6.  
Environment can, in some cases, be altered to protect against development of AN, and of 
eating disorders in general, and positive nutrition communication that does not focus on 
weight, given the fact that preoccupation with weight in a family community can heighten risk, 
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